Rationalizing PROTAC-Mediated Ternary Complex Formation Using Rosetta

被引:77
|
作者
Bai, Nan [1 ,2 ]
Miller, Sven A. [1 ]
Andrianov, Grigorii, V [1 ,3 ]
Yates, Max [1 ]
Kirubakaran, Palani [1 ]
Karanicolas, John [1 ]
机构
[1] Fox Chase Canc Ctr, Program Mol Therapeut, Philadelphia, PA 19111 USA
[2] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA
[3] Kazan Fed Univ, Inst Fundamental Med & Biol, Kazan 420008, Russia
基金
美国国家科学基金会;
关键词
Binding energy - Biosynthesis - Computational methods;
D O I
10.1021/acs.jcim.0c01451
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Proteolysis-targeting chimaeras (PROTACs) are molecules that combine a target-binding warhead with an E3 ligase-recruiting moiety; by drawing the target protein into a ternary complex with the E3 ligase, PROTACs induce target protein degradation. While PROTACs hold exciting potential as chemical probes and as therapeutic agents, development of a PROTAC typically requires synthesis of numerous analogs to thoroughly explore variations on the chemical linker; without extensive trial and error, it is unclear how to link the two protein-recruiting moieties to promote formation of a productive ternary complex. Here, we describe a structure-based computational method for evaluating the suitability of a given linker for ternary complex formation. Our method uses Rosetta to dock the protein components and then builds the PROTAC from its component fragments into each binding mode; complete models of the ternary complex are then refined. We apply this approach to retrospectively evaluate multiple PROTACs from the literature, spanning diverse target proteins. We find that modeling ternary complex formation is sufficient to explain both activity and selectivity reported for these PROTACs, implying that other cellular factors are not key determinants of activity in these cases. We further find that interpreting PROTAC activity is best approached using an ensemble of structures of the ternary complex rather than a single static conformation and that members of a structurally conserved protein family can be recruited by the same PROTAC through vastly different binding modes. To encourage adoption of these methods and promote further analyses, we disseminate both the computational methods and the models of ternary complexes.
引用
收藏
页码:1368 / 1382
页数:15
相关论文
共 50 条
  • [21] PROTAC-Mediated Degradation of Bruton's Tyrosine Kinase Is Inhibited by Covalent Binding
    Tinworth, Christopher P.
    Lithgow, Hannah
    Dittus, Lars
    Bassi, Zuni I.
    Hughes, Sophie E.
    Muelbaier, Marcel
    Dai, Han
    Smith, Ian E. D.
    Kerr, William J.
    Burley, Glenn A.
    Bantscheff, Marcus
    Harling, John D.
    ACS CHEMICAL BIOLOGY, 2019, 14 (03) : 342 - 347
  • [22] Blocking Non-enzymatic Functions by PROTAC-Mediated Targeted Protein Degradation
    Sun, Donghuan
    Zhang, Jing
    Dong, Guoqiang
    He, Shipeng
    Sheng, Chunquan
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (21) : 14276 - 14288
  • [23] PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase
    Bikash Adhikari
    Jelena Bozilovic
    Mathias Diebold
    Jessica Denise Schwarz
    Julia Hofstetter
    Martin Schröder
    Marek Wanior
    Ashwin Narain
    Markus Vogt
    Nevenka Dudvarski Stankovic
    Apoorva Baluapuri
    Lars Schönemann
    Lorenz Eing
    Pranjali Bhandare
    Bernhard Kuster
    Andreas Schlosser
    Stephanie Heinzlmeir
    Christoph Sotriffer
    Stefan Knapp
    Elmar Wolf
    Nature Chemical Biology, 2020, 16 : 1179 - 1188
  • [24] PROTAC-mediated antigen degradation: A novel strategy to enhance CTL responses against cancer
    Mishra, Gunja
    Geers, Daryl
    Voerman, Jane Sa
    Mezzanotte, Laura
    Schliehe, Christopher
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 31 - 31
  • [25] A caged E3 ligase ligand for PROTAC-mediated protein degradation with light
    Kounde, Cyrille S.
    Shchepinova, Maria M.
    Saunders, Charlie N.
    Muelbaier, Marcel
    Rackham, Mark D.
    Harling, John D.
    Tate, Edward W.
    CHEMICAL COMMUNICATIONS, 2020, 56 (41) : 5532 - 5535
  • [26] PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase
    Adhikari, Bikash
    Bozilovic, Jelena
    Diebold, Mathias
    Schwarz, Jessica Denise
    Hofstetter, Julia
    Schroeder, Martin
    Wanior, Marek
    Narain, Ashwin
    Vogt, Markus
    Dudvarski Stankovic, Nevenka
    Baluapuri, Apoorva
    Schoenemann, Lars
    Eing, Lorenz
    Bhandare, Pranjali
    Kuster, Bernhard
    Schlosser, Andreas
    Heinzlmeir, Stephanie
    Sotriffer, Christoph
    Knapp, Stefan
    Wolf, Elmar
    NATURE CHEMICAL BIOLOGY, 2020, 16 (11) : 1179 - +
  • [27] Extended pharmacodynamic responses observed upon PROTAC-mediated degradation of RIPK2
    Alina Mares
    Afjal H. Miah
    Ian E. D. Smith
    Mark Rackham
    Aditya R. Thawani
    Jenni Cryan
    Pamela A. Haile
    Bartholomew J. Votta
    Allison M. Beal
    Carol Capriotti
    Michael A. Reilly
    Don T. Fisher
    Nico Zinn
    Marcus Bantscheff
    Thomas T. MacDonald
    Anna Vossenkamper
    Phoebe Dace
    Ian Churcher
    Andrew B. Benowitz
    Gillian Watt
    Jane Denyer
    Paul Scott-Stevens
    John D. Harling
    Communications Biology, 3
  • [28] Non-invasive in vivo monitoring of PROTAC-mediated protein degradation using an environment-sensitive reporter
    Li, Tao
    Zong, Qingyu
    Dong, He
    Ullah, Ihsan
    Pan, Zhenhai
    Yuan, Youyong
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [29] Optimization of PROTAC Ternary Complex Using DNA Encoded Library Approach
    Chen, Qiuxia
    Liu, Chuan
    Wang, Wei
    Meng, Xiaoyun
    Cheng, Xuemin
    Li, Xianyang
    Cai, Longying
    Luo, Linfu
    He, Xu
    Qu, Huan
    Luo, Jing
    Wei, Hong
    Gao, Sen
    Liu, Guansai
    Wan, Jinqiao
    Israel, David I.
    Li, Jin
    Dou, Dengfeng
    ACS CHEMICAL BIOLOGY, 2023, 18 (01) : 25 - 33
  • [30] PROTAC-mediated vimentin degradation promotes terminal erythroid differentiation of pluripotent stem cells
    Yan, Hao
    Zang, Ruge
    Cui, Tiantian
    Liu, Yiming
    Zhang, Biao
    Zhao, Lingpin
    Li, Hongyu
    Zhou, Juannian
    Wang, Haiyang
    Zeng, Quan
    Xu, Lei
    Zhou, Yuqi
    Pei, Xuetao
    Xi, Jiafei
    Yue, Wen
    STEM CELL RESEARCH & THERAPY, 2024, 15 (01)